Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

Pharmacokinetic/Pharmacodynamic Analysis of a Hemodialyzed Patient Treated with 25 mg of Sunitinib.

Noda S, Kageyama S, Tsuru T, Kubota S, Yoshida T, Okamoto K, Okada Y, Morita SY, Terada T.

Case Rep Oncol. 2012 Sep;5(3):627-32. doi: 10.1159/000345694. Epub 2012 Sep 21.

PMID:
23275777
[PubMed]
Free PMC Article
2.

Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors.

Adams VR, Leggas M.

Clin Ther. 2007 Jul;29(7):1338-53. Review.

PMID:
17825686
[PubMed - indexed for MEDLINE]
3.

Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis.

Houk BE, Bello CL, Poland B, Rosen LS, Demetri GD, Motzer RJ.

Cancer Chemother Pharmacol. 2010 Jul;66(2):357-71. doi: 10.1007/s00280-009-1170-y. Epub 2009 Dec 5. Review.

PMID:
19967539
[PubMed - indexed for MEDLINE]
4.

Response to sorafenib after sunitinib-induced acute heart failure in a patient with metastatic renal cell carcinoma: case report and review of the literature.

Wong MK, Jarkowski A.

Pharmacotherapy. 2009 Apr;29(4):473-8. doi: 10.1592/phco.29.4.473. Review.

PMID:
19323623
[PubMed - indexed for MEDLINE]
5.

Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies.

Papaetis GS, Syrigos KN.

BioDrugs. 2009;23(6):377-89. doi: 10.2165/11318860-000000000-00000. Review.

PMID:
19894779
[PubMed - indexed for MEDLINE]
6.

Sunitinib.

Deeks ED, Keating GM.

Drugs. 2006;66(17):2255-66; discussion 2267-8. Review.

PMID:
17137406
[PubMed - indexed for MEDLINE]
7.

Benefit-risk assessment of sunitinib in gastrointestinal stromal tumours and renal cancer.

Theou-Anton N, Faivre S, Dreyer C, Raymond E.

Drug Saf. 2009;32(9):717-34. doi: 10.2165/00002018-200932090-00003. Review.

PMID:
19670913
[PubMed - indexed for MEDLINE]
8.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
[PubMed - indexed for MEDLINE]
9.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
[PubMed - indexed for MEDLINE]
10.

Clinical pharmacokinetics and pharmacodynamics of vildagliptin.

He YL.

Clin Pharmacokinet. 2012 Mar 1;51(3):147-62. doi: 10.2165/11598080-000000000-00000. Review.

PMID:
22339447
[PubMed - indexed for MEDLINE]
11.

Sorafenib and sunitinib: novel targeted therapies for renal cell cancer.

Grandinetti CA, Goldspiel BR.

Pharmacotherapy. 2007 Aug;27(8):1125-44. Review.

PMID:
17655513
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk